Stocks To Watch: Tandem Diabetes Care, Inc. (TNDM) Is Creating Trading Opportunities

Tandem Diabetes Care, Inc. (TNDM) has seen some recent activity in the stock market and its stock finished trading at $114.13 yesterday. Investors are starting to take notice of TNDM as the stock traded as high as $115.23 and as low as $110.93 in the prior market day.

Tandem Diabetes Care, Inc. (TNDM) average trading volume is 716.44K. However, in the prior market day Tandem Diabetes Care, Inc. (TNDM) traded 525,757 shares. The First downside support level on TNDM is $109.87 and the First upside resistance level on TNDM is $122.60. TNDM 50 day moving average is $111.79 and TNDM 200-day moving average is $95.87.

Tandem Diabetes Care, Inc. (TNDM) most recent performance has been specified by the recent movement in TNDM stock. TNDM has performed 6.38% over the past 30 days, TNDM has performed 13.78% over the past 3 months and TNDM has shown 86.03% over the past 1 year. Tandem Diabetes Care, Inc. (TNDM) has a 52 week range of $43.69 to $123.74. Tandem Diabetes Care, Inc. (TNDM) is trading 161.23% from its 52 week low and -7.77% from its 52 week high. Tandem Diabetes Care, Inc. (TNDM) is indicating a 5.62% short float indicating the amount short in the float.

TNDM has 60.42M shares outstanding and 58.83M shares in the float. Tandem Diabetes Care, Inc. (TNDM) at this time has a market cap of $7.12B and income of -42.20M. The EPS next quarter for TNDM is -0.11 and projected EPS next year is 111.60%. The market cap of Tandem Diabetes Care, Inc. (TNDM) at $7.12B signifies how many Investors own shares of TNDM and is calculated off the last price ($114.13) of TNDM and the amount of shares outstanding (60.42M) with Tandem Diabetes Care, Inc. (TNDM).

Tandem Diabetes Care, Inc. (TNDM) has aggregate cash (mrq) of 426.28M, aggregate cash per share (mrq) of 7, aggregate debt of TNDM stands at 222.28M and aggregate debt/equity (mrq) is 83.03. . Tandem Diabetes Care, Inc. (TNDM) operating cash flow (ttm) is 37.33M, TNDM leveraged free cash flow (ttm) is 19.12M.

TNDM is trading -0.50% below (bearish) its SMA20, 3.51% above (bullish) its SMA50 and 29.72% above (bullish) its SMA200.

Related Articles

Dada Group (NASDAQ: DADA) Extends Partnership With Lianhua Supermarket

Dada Group (NASDAQ: DADA) has disclosed that it has extended its strategic partnership with Lianhua Supermarket Holdings Co., Ltd. Both the companies aimed to focus...

Diana Shipping (NYSE: DSX) Signs Time Charter Contract With CLdN Cobelfret

Diana Shipping (NYSE: DSX) has revealed that it has signed a time charter contract with CLdN Cobelfret SA through its fully-owned unit. US$12,100 is...

Biogen (NASDAQ: BIIB) And Sage Therapeutics Inks Agreement To Develop Therapies For Depression

Biogen Inc. (NASDAQ: BIIB) and Sage Therapeutics, Inc. (NASDAQ: SAGE) communicated that they are partnering together and will be combining their efforts to develop...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Dada Group (NASDAQ: DADA) Extends Partnership With Lianhua Supermarket

Dada Group (NASDAQ: DADA) has disclosed that it has extended its strategic partnership with Lianhua Supermarket Holdings Co., Ltd. Both the companies aimed to focus...

Diana Shipping (NYSE: DSX) Signs Time Charter Contract With CLdN Cobelfret

Diana Shipping (NYSE: DSX) has revealed that it has signed a time charter contract with CLdN Cobelfret SA through its fully-owned unit. US$12,100 is...

Biogen (NASDAQ: BIIB) And Sage Therapeutics Inks Agreement To Develop Therapies For Depression

Biogen Inc. (NASDAQ: BIIB) and Sage Therapeutics, Inc. (NASDAQ: SAGE) communicated that they are partnering together and will be combining their efforts to develop...

BBVA And Sabadell Ends Talks Of A Merger Due To Conflict Over Price

Banco Bilbao Vizcaya Argentaria S.A. (NYSE: BBVA) and Banco de Sabadell SA have discussed the terms of a merger but the negotiation turned out...

Hancock Jaffe (NASDAQ: HJLI) Confirms 1:25 Reverse Stock Split

Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI), a company that manufactures medical devices used to treat heart problems, publicized that its Board of Directors has...